Search Results - "De Angelis, Marcello"

Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study by Buonomo, Antonio Riccardo, Viceconte, Giulio, Calabrese, Massimiliano, De Luca, Giovanna, Tomassini, Valentina, Cavalla, Paola, Maniscalco, Giorgia Teresa, Ferraro, Diana, Nociti, Viviana, Radaelli, Marta, Buscarinu, Maria Chiara, Paolicelli, Damiano, Gajofatto, Alberto, Annovazzi, Pietro, Pinardi, Federica, Di Filippo, Massimiliano, Cordioli, Cinzia, Zappulo, Emanuela, Scotto, Riccardo, Gentile, Ivan, Spiezia, Antonio Luca, Petruzzo, Martina, De Angelis, Marcello, Brescia Morra, Vincenzo, Solaro, Claudio, Gasperini, Claudio, Cocco, Eleonora, Moccia, Marcello, Lanzillo, Roberta

“…Background Patients with multiple sclerosis (MS) often receive disease-modifying therapies (DMTs) that can expose them to reactivation of potential occult…”
Get full text

Different cortical excitability profiles in hereditary brain iron and copper accumulation by Dubbioso, Raffaele, Ruggiero, Lucia, Esposito, Marcello, Tarantino, Paola, De Angelis, Marcello, Aruta, Francesco, Pappatà, Sabina, Ugga, Lorenzo, Piperno, Alberto, Iorio, Raffaele, Santoro, Lucio, Iodice, Rosa, Manganelli, Fiore

“…Background and aim Neurodegeneration with brain iron accumulation (NBIA) and Wilson’s disease (WD) is considered the prototype of neurodegenerative disorders…”
Get full text

From Alpine-type sulfides to nonsulfides in the Gorno Zn project (Bergamo, Italy) by Mondillo, Nicola, Lupone, Federica, Boni, Maria, Joachimski, Michael, Balassone, Giuseppina, De Angelis, Marcello, Zanin, Simone, Granitzio, Fabio

“…Recent exploration of the Gorno Zn-Pb-Ag deposit in northern Italy identified 3.3 Mt of sulfides at 4.9% Zn, 1.3% Pb, and 27.2 g/t Ag (indicated+inferred…”
Get full text

Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience by Zecca, Chiara, Bovis, Francesca, Novi, Giovanni, Capobianco, Marco, Lanzillo, Roberta, Frau, Jessica, Repice, Anna Maria, Hakiki, Bahia, Realmuto, Sabrina, Bonavita, Simona, Curti, Erica, Brambilla, Laura, Mataluni, Giorgia, Cavalla, Paola, Di Sapio, Alessia, Signoriello, Elisabetta, Barone, Stefania, Maniscalco, Giorgia T, Maietta, Ilaria, Maraffi, Isabella, Boffa, Giacomo, Malucchi, Simona, Nozzolillo, Agostino, Coghe, Giancarlo, Mechi, Claudia, Salemi, Giuseppe, Gallo, Antonio, Sacco, Rosaria, Cellerino, Maria, Malentacchi, Maria, De Angelis, Marcello, Lorefice, Lorena, Magnani, Eliana, Prestipino, Elio, Sperli, Francesca, Brescia Morra, Vincenzo, Fenu, Giuseppe, Barilaro, Alessandro, Abbadessa, Gianmarco, Signori, Alessio, Granella, Franco, Amato, Maria Pia, Uccelli, Antonio, Gobbi, Claudio, Sormani, Maria Pia

“…Background: Rituximab, an anti-CD20 monoclonal antibody leading to B lymphocyte depletion, is increasingly used as an off-label treatment option for multiple…”
Get full text

Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis by Cennamo, Gilda, Carotenuto, Antonio, Montorio, Daniela, Petracca, Maria, Moccia, Marcello, Melenzane, Antonietta, Tranfa, Fausto, Lamberti, Anna, Spiezia, Antonio L., Servillo, Giuseppe, De Angelis, Marcello, Petruzzo, Martina, Criscuolo, Chiara, Lanzillo, Roberta, Brescia Morra, Vincenzo

“…Background: To evaluate retinal vessel density (VD) in macular and in peripapillary regions in patients with recent onset of multiple sclerosis, at initial…”
Get full text

Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study by Carotenuto, Antonio, Costabile, Teresa, De Lucia, Mario, Moccia, Marcello, Falco, Fabrizia, Petruzzo, Martina, De Angelis, Marcello, Russo, Cinzia Valeria, Saccà, Francesco, Lanzillo, Roberta, Brescia Morra, Vincenzo

“…Nabiximols is an effective treatment for spasticity in MS. However, treatment discontinuation over-time might occur and predictors of sustained treatment…”
Get full text

Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 Trials by Moccia, Marcello, Lanzillo, Roberta, Petruzzo, Martina, Nozzolillo, Agostino, De Angelis, Marcello, Carotenuto, Antonio, Palladino, Raffaele, Brescia Morra, Vincenzo

“…Background: Cladribine is approved for the treatment of highly-active relapsing multiple sclerosis (MS), where it is also effective on disability progression…”
Get full text

Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study by Buonomo, Antonio Riccardo, Viceconte, Giulio, Calabrese, Massimiliano, De Luca, Giovanna, Tomassini, Valentina, Cavalla, Paola, Maniscalco, Giorgia Teresa, Ferraro, Diana, Nociti, Viviana, Radaelli, Marta, Buscarinu, Maria Chiara, Paolicelli, Damiano, Gajofatto, Alberto, Annovazzi, Pietro, Pinardi, Federica, Di Filippo, Massimiliano, Cordioli, Cinzia, Zappulo, Emanuela, Scotto, Riccardo, Gentile, Ivan, Spiezia, Antonio Luca, Petruzzo, Martina, De Angelis, Marcello, Morra, Vincenzo Brescia, Solaro, Claudio, Gasperini, Claudio, Cocco, Eleonora, Moccia, Marcello, Lanzillo, Roberta

Get full text

Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions by Vola, Elena Augusta, Petracca, Maria, Cocozza, Sirio, De Angelis, Marcello, Carotenuto, Antonio, Pontillo, Giuseppe, Morra, Vincenzo Brescia, Tedeschi, Enrico, Lanzillo, Roberta

“…Progressive multifocal leukoencephalopathy (PML) can rarely occur in Multiple Sclerosis (MS) patients undergoing dimethyl fumarate (DMF) treatment. Our case…”
Get full text

Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice by De Angelis, Marcello, Petracca, Maria, Lanzillo, Roberta, Brescia Morra, Vincenzo, Moccia, Marcello

“…The use of disease-modifying therapies (DMTs) in multiple sclerosis (MS) could affect COVID-19 outcomes by modulating the immune response, which, in turn,…”
Get full text

Digital Technology in Clinical Trials for Multiple Sclerosis: Systematic Review by De Angelis, Marcello, Lavorgna, Luigi, Carotenuto, Antonio, Petruzzo, Martina, Lanzillo, Roberta, Brescia Morra, Vincenzo, Moccia, Marcello

“…Clinical trials in multiple sclerosis (MS) have been including digital technology tools to overcome limitations in treatment delivery and disease monitoring…”
Get full text

Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis by Capasso, Nicola, Nozzolillo, Agostino, Scalia, Giulia, Lanzillo, Roberta, Carotenuto, Antonio, De Angelis, Marcello, Petruzzo, Martina, Saccà, Francesco, Russo, Cinzia Valeria, Brescia Morra, Vincenzo, Moccia, Marcello

“…•Rituximab and ocrelizumab have a similar effect on B-lymphocyte depletion•T lymphocyte reduction is more pronounced in ocrelizumab, when compared with…”
Get full text

The impact of diagnostic criteria and treatments on the 20-year costs for treating relapsing-remitting multiple sclerosis by Petruzzo, Martina, Palladino, Raffaele, Nardone, Antonio, Nozzolillo, Agostino, Servillo, Giuseppe, Orlando, Valentina, De Angelis, Marcello, Lanzillo, Roberta, Brescia Morra, Vincenzo, Moccia, Marcello

“…•Costs for treating multiple sclerosis decreased by 0.4% per patient after the introduction of 2011 diagnostic criteria.•The highest slope change in annual…”
Get full text

Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study by Lanzillo, Roberta, Carotenuto, Antonio, Signoriello, Elisabetta, Iodice, Rosa, Miele, Giuseppina, Bisecco, Alvino, Maniscalco, Giorgia Teresa, Sinisi, Leonardo, Romano, Felice, Di Gregorio, Maria, Lavorgna, Luigi, Trojsi, Francesca, Moccia, Marcello, Fratta, Mario, Capasso, Nicola, Dubbioso, Raffaele, Petracca, Maria, Spiezia, Antonio Luca, Gallo, Antonio, Petruzzo, Martina, De Angelis, Marcello, Bonavita, Simona, Lus, Giacomo, Tedeschi, Gioacchino, Brescia Morra, Vincenzo

“…Pivotal trials showed the effectiveness of the monoclonal antibody ocrelizumab in relapsing and progressive multiple sclerosis (MS). However, data on everyday…”
Get full text

Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice by De Angelis, Marcello, Petracca, Maria, Lanzillo, Roberta, Brescia Morra, Vincenzo, Moccia, Marcello

“…BACKGROUNDThe use of disease-modifying therapies (DMTs) in multiple sclerosis (MS) could affect COVID-19 outcomes by modulating the immune response, which, in…”
Get full text

Recensioni: "'Cantate Domino'. Musica nei secoli per il Duomo di Firenze," a cura di Piero Gargiulo, Gabriele Giacomelli, Carolyn Gianturco by de Angelis, Marcello

“…A collection of papers about the history of music written for and performed at the cathedral of Florence, Italy--the "mystical and architectural heart of the…”
Get full text

'Cantate Domino'. Musica nei secoli per il Duomo di Firenze, atti del convegno internazionale (Firenze, 23-25 maggio 1997), (Atti del VII Centenario del Duomo di Firenze, 3, a cura di Timothy Verdon e Annalisa Innocenti) by de Angelis, Marcello

Get full text

Ruggero Leoncavallo nel suo tempo by de Angelis, Marcello

Get full text

Melodramma, spettacolo e musica nella Firenze dei Lorena: Francesco I, Pietro Leopoldo, Ferdinando III (1750-1800): Repertorio by Rice, John A.

Get full text